219 related articles for article (PubMed ID: 25761374)
1. Respiratory dysfunction in Charcot-Marie-Tooth disease type 1A.
de Carvalho Alcântara M; Nogueira-Barbosa MH; Fernandes RM; da Silva GA; Lourenço CM; Sander HH; Marques Junior W
J Neurol; 2015 May; 262(5):1164-71. PubMed ID: 25761374
[TBL] [Abstract][Full Text] [Related]
2. Phrenic nerve involvement and respiratory muscle weakness in patients with Charcot-Marie-Tooth disease 1A.
Spiesshoefer J; Henke C; Kabitz HJ; Akova-Oeztuerk E; Draeger B; Herkenrath S; Randerath W; Young P; Brix T; Boentert M
J Peripher Nerv Syst; 2019 Sep; 24(3):283-293. PubMed ID: 31393643
[TBL] [Abstract][Full Text] [Related]
3. Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study.
Dematteis M; Pépin JL; Jeanmart M; Deschaux C; Labarre-Vila A; Lévy P
Lancet; 2001 Jan; 357(9252):267-72. PubMed ID: 11214130
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Respiratory Muscle Strength and Pulmonary Function in Patients with Charcot-Marie-Tooth Disease Type 2.
Garcez CA; Neves EL; Melo SM; Nunes PS; Barreto LC; Costa IM; Souza CC; Rezende RL; Araújo AA
Eur Neurol; 2015; 74(5-6):310-4. PubMed ID: 26674657
[TBL] [Abstract][Full Text] [Related]
5. Sleep disorders in Charcot-Marie-Tooth disease type 1.
Boentert M; Knop K; Schuhmacher C; Gess B; Okegwo A; Young P
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):319-25. PubMed ID: 23704315
[TBL] [Abstract][Full Text] [Related]
6. Charcot-Marie-Tooth disease with diaphragmatic weakness.
Osanai S; Akiba Y; Nakano H; Matsumoto H; Yahara O; Onodera S
Intern Med; 1992 Nov; 31(11):1267-70. PubMed ID: 1295621
[TBL] [Abstract][Full Text] [Related]
7. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.
Sevilla T; Jaijo T; Nauffal D; Collado D; Chumillas MJ; Vilchez JJ; Muelas N; Bataller L; Domenech R; Espinós C; Palau F
Brain; 2008 Nov; 131(Pt 11):3051-61. PubMed ID: 18812441
[TBL] [Abstract][Full Text] [Related]
8. [Respiratory disorders in type-1 hereditary motor and sensory neuropathy].
Akiba Y; Kimura T; Kitaoka T; Toyoshima E; Fujiuchi S; Osanai S; Nakano H; Ohsaki Y; Yahara O; Kikuchi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Aug; 34(8):850-5. PubMed ID: 8965393
[TBL] [Abstract][Full Text] [Related]
9. Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot-Marie-Tooth disease.
Noto Y; Shiga K; Tsuji Y; Mizuta I; Higuchi Y; Hashiguchi A; Takashima H; Nakagawa M; Mizuno T
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):378-84. PubMed ID: 25091364
[TBL] [Abstract][Full Text] [Related]
10. Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.
Aboussouan LS; Lewis RA; Shy ME
Lung; 2007; 185(1):1-7. PubMed ID: 17294338
[TBL] [Abstract][Full Text] [Related]
11. [A case of Charcot-Marie-Tooth disease (CMT) type 1 complicated by diabetes mellitus (DM) showing bilateral phrenic nerve palsy].
Takakura Y; Furuya H; Yamashita K; Murai H; Araki T; Kikuchi H; Ohyagi Y; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Apr; 42(4):320-2. PubMed ID: 12561089
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study.
Dziewas R; Waldmann N; Böntert M; Hor H; Müller T; Okegwo A; Ringelstein EB; Young P
J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):829-31. PubMed ID: 18559462
[TBL] [Abstract][Full Text] [Related]
13. Nerve conduction velocity in CMT1A: what else can we tell?
Manganelli F; Pisciotta C; Reilly MM; Tozza S; Schenone A; Fabrizi GM; Cavallaro T; Vita G; Padua L; Gemignani F; Laurà M; Hughes RA; Solari A; Pareyson D; Santoro L;
Eur J Neurol; 2016 Oct; 23(10):1566-71. PubMed ID: 27412484
[TBL] [Abstract][Full Text] [Related]
14. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.
Krajewski KM; Lewis RA; Fuerst DR; Turansky C; Hinderer SR; Garbern J; Kamholz J; Shy ME
Brain; 2000 Jul; 123 ( Pt 7)():1516-27. PubMed ID: 10869062
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.
Chao HC; Chou CT; Lee YC; Lin KP
J Neurol Sci; 2015 Nov; 358(1-2):213-20. PubMed ID: 26349404
[TBL] [Abstract][Full Text] [Related]
16. Phrenic involvement in Charcot-Marie-Tooth disease. A pathologic documentation.
Gilchrist D; Chan CK; Deck JH
Chest; 1989 Nov; 96(5):1197-9. PubMed ID: 2553346
[TBL] [Abstract][Full Text] [Related]
17. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
[TBL] [Abstract][Full Text] [Related]
18. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
[TBL] [Abstract][Full Text] [Related]
19. [The application of scales and characteristics of disability in the common genotypes of Charcot-Marie-Tooth disease].
Liu X; Zhang RX; Liu L; Xie YZ; Lin ZQ; Zhao Q; Cao WQ; Zhu XY; Li XB
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):131-136. PubMed ID: 33455129
[No Abstract] [Full Text] [Related]
20. [Respiratory failure due to diaphragmatic dysfunction in Charcot-Marie-Tooth disease: a case report].
Hatakeyama S; Suzuki J; Murakami T; Nagaoka T; Suzuki M; Sakamoto K; Aoki S; Matsuoka R; Uchigata M
Nihon Kokyuki Gakkai Zasshi; 2000 Aug; 38(8):637-41. PubMed ID: 11061092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]